4.2 Article

High Expression of H3K27me3 Is an Independent Predictor of Worse Outcome in Patients with Urothelial Carcinoma of Bladder Treated with Radical Cystectomy

Journal

BIOMED RESEARCH INTERNATIONAL
Volume 2013, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2013/390482

Keywords

-

Funding

  1. National Nature Science Foundation of China [81225018, 81172340]
  2. 973 Project of China [2010CB912802, 2010CB529404]
  3. Ph.D. Programs Foundation of Ministry of Education of China [20110171110078]

Ask authors/readers for more resources

It has been suggested that trimethylation of lysine 27 on histone H3 (H3K27me3) is a crucial epigenetic process in tumorigenesis. However, the expression pattern of H3K27me3 and its clinicopathological/prognostic significance in urothelial carcinoma of bladder (UCB) are unclear. In this study, upregulated expression of H3K27me3 protein was observed in the majority of UCBs by Western blotting. High expression of H3K27me3 was examined by IHC in 59/126 (46.8%) of UCB tissues and in 18/72 (25.0%) of normal urothelial bladder epithelial tissues (P = 0.002). High expression of H3K27me3 was associated with multifocal tumors and lymph node metastases (P < 0.05). Patients with high expression of H3K27me3 had shorter cancer-specific survival (CSS) time than patients with low expression of H3K27me3 (P < 0.001). In different subsets of UCB patients, high expression of H3K27me3 was also a prognostic indicator in patients with grade 2 and grade 3, pT1, pT2, pT3, and pN-disease (P < 0.05). Importantly, expression of H3K27me3 was an independent predictor for CSS (P < 0.001) of UCB patients treated with radical cystectomy (RC). Our data suggests that high expression of H3K27me3 is an independent molecular marker for predicting poor prognosis of UCB patients treated with RC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets

Shu-peng Chen, Bao-xin Liu, Jie Xu, Xiao-feng Pei, Yi-ji Liao, Feng Yuan, Fang Zheng

BMC CANCER (2015)

Article Oncology

MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16

Dong Qian, Kailin Chen, Haixia Deng, Huilan Rao, Huiqiang Huang, Yiji Liao, Xiaofei Sun, Suying Lu, Zhiyong Yuan, Dan Xie, Qingqing Cai

CLINICAL CANCER RESEARCH (2015)

Article Oncology

Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma

Lin-Lin Huang, Yi Zhang, Jia-Xing Zhang, Long-Jun He, Ying-Rong Lai, Yi-Ji Liao, Xiao-Peng Tian, Hai-Xia Deng, Ying-Jie Liang, Hsiang-Fu Kung, Dan Xie, Sen-Lin Zhu

TUMOR BIOLOGY (2015)

Article Gastroenterology & Hepatology

Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer

Long-Jun He, Dan Xie, Pin-Jin Hu, Yi-Ji Liao, Hai-Xia Deng, Hsiang-Fu Kung, Sen-Lin Zhu

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Multidisciplinary Sciences

Evidence for transcriptional interference in a dual-luciferase reporter system

Guo-Qing Wu, Xiao Wang, Hong-Ying Zhou, Ke-Qun Chai, Qian Xue, Ai-Hong Zheng, Xiu-Ming Zhu, Jian-Yong Xiao, Xu-Hua Ying, Fu-Wei Wang, Tao Rui, Li-Yun Xu, Yong-Kui Zhang, Yi-Ji Liao, Dan Xie, Li-Qin Lu, Dong-Sheng Huang

SCIENTIFIC REPORTS (2015)

Article Genetics & Heredity

Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets

Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, Tian-Hao Liu, Shu-Peng Chen, Pei-Hong Wu, Long Wu, Xiu-Wu Bian, Xin-Yuan Guan, Yi-Xin Zeng, Yun-Fei Yuan, Hsiang-Fu Kung, Dan Xie

PLOS GENETICS (2015)

Article Oncology

CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma

Chang-Peng Li, Mu-Yan Cai, Li-Juan Jiang, Shi-Juan Mai, Jie-Wei Chen, Feng-Wei Wang, Yi-Ji Liao, Wen-Hui Chen, Xiao-Han Jin, Xiao-Qing Pei, Xin-Yuan Guan, Mu-Sheng Zeng, Dan Xie

CARCINOGENESIS (2016)

Article Biochemistry & Molecular Biology

Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B

X-D Li, J-X Zhang, L-J Jiang, F-W Wang, L-L Liu, Y-J Liao, X-H Jin, W-H Chen, X. Chen, S-J Guo, F-J Zhou, Y-X Zeng, X-Y Guan, Z-W Liu, D. Xie

ONCOGENE (2016)

Article Oncology

The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis

Tian-Hao Liu, Fang Zheng, Mu-Yan Cai, Lin Guo, Huan-Xin Lin, Jie-Wei Chen, Yi-Ji Liao, Hsiang-Fu Kung, Yi-Xin Zeng, Dan Xie

ONCOTARGET (2016)

Article Oncology

Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1

Guo-Qing Wu, Ke-Qun Chai, Xiu-Ming Zhu, Hua Jiang, Xiao Wang, Qian Xue, Ai-Hong Zheng, Hong-Ying Zhou, Yun Chen, Xiao-Chen Chen, Jian-Yong Xiao, Xu-Hua Ying, Fu-Wei Wang, Tao Rui, Yi-Ji Liao, Dan Xie, Li-Qin Lu, Dong-Sheng Huang

ONCOTARGET (2016)

Article Cell & Tissue Engineering

Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis

Hai-Yan Bai, Yi-Ji Liao, Mu-Yan Cai, Ning-Fang Ma, Qi Zhang, Jie-Wei Chen, Jia-Xing Zhang, Feng-Wei Wang, Chen-Yuan Wang, Wen-Hui Chen, Xiao-Han Jin, Rui-Hua Xu, Xin-Yuan Guan, Dan Xie

STEM CELLS (2018)

Article Biochemistry & Molecular Biology

FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1

Wen-Hui Chen, Mu-Yan Cai, Jia-Xing Zhang, Feng-Wei Wang, Lin-Quan Tang, Yi-Ji Liao, Xiao-Han Jin, Chen-Yuan Wang, Ling Guo, Yi-Guo Jiang, Cai-Ping Ren, Hai-Qiang Mai, Mu-Sheng Zeng, Hsiang-Fu Kung, Chao-Nan Qian, Dan Xie

ONCOGENE (2018)

Review Andrology

Epigenetic regulation of prostate cancer: the theories and the clinical implications

Yiji Liao, Kexin Xu

ASIAN JOURNAL OF ANDROLOGY (2019)

Article Oncology

PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer

Juyeong Hong, Ji Hoon Lee, Zhao Zhang, Yanming Wu, Mei Yang, Yiji Liao, Richard de la Rosa, Jessica Scheirer, Douglas Pechacek, Nu Zhang, Zhenming Xu, Tyler Curiel, Xi Tan, Tim H. -M. Huang, Kexin Xu

Summary: Inhibition of cancer-intrinsic EZH2 promotes antitumor immunity in breast cancer, requiring specific activation of type I IFN signaling. High levels of EZH2 and low levels of STAT2 in breast cancer patients are associated with the worst antitumor immune responses.

CANCER RESEARCH (2022)

Article Oncology

Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ER alpha-GREB1 Transcriptional Axis

Yanming Wu, Zhao Zhang, Mauro E. Cenciarini, Cecilia J. Proietti, Matias Amasino, Tao Hong, Mei Yang, Yiji Liao, Huai-Chin Chiang, Virginia G. Kaklamani, Rinath Jeselsohn, Ratna K. Vadlamudi, Tim Hui-Ming Huang, Rong Li, Carmine De Angelis, Xiaoyong Fu, Patricia V. Elizalde, Rachel Schiff, Myles Brown, Kexin Xu

CANCER RESEARCH (2018)

No Data Available